SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

Certain information concerning the Company’s segments is presented in the following tables (in thousands):

	For the Three Months Ended						For the Nine Months Ended
	September 30,						September 30,
	2022			2021			2022			2021
Net revenues:
Reportable segments:
Regenerative medicine	$	–		$	–		$	–		$	2,924
Contract services		–			1,116			814			5,438
Total net revenues	$	–		$	1,116		$	814		$	8,362
Net (loss)/income:
Reportable segments:
Regenerative medicine	$	(3,413	)	$	(972	)	$	(6,836	)	$	(21,903	)
Contract services		13			(49	)		(403	)		284
Total net loss	$	(3,400	)	$	(1,021	)	$	(7,239	)	$	(21,619	)